Quantcast

Latest Thalidomide Stories

2009-12-16 07:35:00

Trial conducted pursuant to Special Protocol Assessment with the Food and Drug Administration QUEBEC CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.

2009-12-07 14:17:48

Carfilzomib induces a response in 45 percent of patients and reduces neuropathy.

2009-12-07 07:35:00

Response Rate Increases to 41% and Median Overall Survival Reported at 25 Months for All Evaluable Patients QUEBEC CITY, Dec. 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.

2009-12-07 07:00:00

NEW ORLEANS, Dec. 7 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced results from an ongoing Phase 2 study, known as the 004 study, of the company's lead proteasome inhibitor, carfilzomib.

2009-11-17 11:25:29

'Renaissance' in use may lead to new treatments for controversial drug.

2009-09-13 16:27:41

A British man Sunday said he will protest the government's refusal to compensate victims of the drug Thalidomide, administered to their mothers while pregnant.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.